April 24, 2026 9:18 PM
Kedrion warns MidEast conflict may delay plasma supplies to Iran
Italian biopharmaceutical company Kedrion said on Friday it may struggle to ensure timely delivery of vital plasma-based medicines to patients in Iran if the conflict with the United States and Israel creates supply chain disruptions. Chief Executive Ugo Di Francesco said the company, whose results released this week confirmed robust growth over the last few years, was worried about the impact of surging fuel prices on its logistics costs. "If the situation were to persist over time, challenge...


